Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announces that Dream Sock™ has received official certification from Australia’s Therapeutic Goods Administration (TGA), meeting rigorous standards required for medical devices in the region.
“TGA certification of Dream Sock marks an important step forward in our global expansion, bringing more families worldwide access to the latest pediatric health monitoring technology,” said Jonathan Harris, Owlet’s President. “For parents in these markets, certification means they will soon have access to a trusted, medically-certified tool to support their baby’s health and well-being.”
Dream Sock is a wearable smart baby monitor, designed for healthy infants between 0-18 months or 2.5-13.6 kg, that tracks key health indicators such as pulse rate, oxygen level, and sleep patterns. The connected Owlet Dream App displays readings in real-time, and both the Dream App and the included Base Station provide notifications if measurements fall outside preset ranges.
Having monitored over two million babies globally, Owlet is expanding access to its newly certified medical device to give more families peace of mind. Dream Sock is expected to be available for purchase later this year in Australia and New Zealand through the Company’s local website and retail partners, including Baby Bunting. Parents can sign up at www.owletcare.com.au to be notified when Dream Sock is available and learn more about Owlet.